IMM 4.92% 32.0¢ immutep limited

Secondary endpoints can be validly analysed, even if the primary...

  1. 1,606 Posts.
    lightbulb Created with Sketch. 380

    Secondary endpoints can be validly analysed, even if the primary endpoint does not provide clear statistical significance

    Secondary outcomes are extremely important in early phase trials when the full benefits are still being discovered.

    https://pubmed.ncbi.nlm.nih.gov/9408718/
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
0.015(4.92%)
Mkt cap ! $464.8M
Open High Low Value Volume
30.0¢ 32.5¢ 30.0¢ $1.168M 3.702M

Buyers (Bids)

No. Vol. Price($)
5 148547 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 51809 2
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.